The Disrupt Stage is where many of the biggest conversations in technology happen, with a legacy that stretches back for more ...

Suivez le Mondial 2026 avec Les Numériques et découvrez le calendrier des matchs de ce vendredi, avec les horaires des coups d'envoi et les options pour voir les ...

The South Florida Water Management District's Python Elimination Program rewards hunters for removing the invasive snakes. In May 2026, contracted hunters eliminated 315 python eggs from the ...

The website for the popular JDownloader download manager was compromised earlier this week to distribute malicious Windows and Linux installers, with the Windows payload found deploying a Python-based ...

The ACS Approval Program promotes excellence in chemistry education for undergraduate students through approval of baccalaureate chemistry programs. ACS-approved programs offer a broad-based and ...

Replimune (REPL) has announced that it has no other option but to reduce its workforce and scale back U.S. manufacturing operations after the FDA on Friday declined to approve its lead asset, RP1, ...

Everged is rolling out a new program aimed at fixing one of the EV industry’s most persistent problems: broken and outdated chargers that never seem to get repaired. The Vienna, Virginia-based energy ...

No more waiting on slow-loading modules or wasting time on ad hoc workarounds: Python 3.15’s new ‘lazy imports’ mechanism has you covered. When you import a module in Python, the module’s code must be ...

In the era of A.I. agents, many Silicon Valley programmers are now barely programming. Instead, what they’re doing is deeply, deeply weird. Credit...Illustration by Pablo Delcan and Danielle Del Plato ...

Florida's Python Elimination Program pays certified hunters to remove the invasive snakes from the Everglades. Burmese pythons have caused a severe decline in native small mammal populations in South ...

In July 2025, REPL announced it had received a CRL for its biologics license application (BLA) for RP1 (vusolimogene oderparepvec) plus nivolumab in advanced melanoma patients who were PD-1 ...